You are here

CTMSS Product Theater Webinar with MAGVENTURE

Vertical Tabs

Vertical Tabs

About MagVenture's Session

Product Theater Webinar: MAGVENTURE

The Advantages of Robotic TMS in The Context of The COVID-19 Pandemic
Format: LIVE

**Webinar log-in information will be sent out via email.

Disclaimer: The content does not necessarily reflect the views and opinions of Clinical TMS Society or its members and is solely determined by the sponsor.

Wednesday, November 18, 2020
5:00 pm PST / 8:00 pm EST
The Advantages of Robotic TMS in The Context of The COVID-19 Pandemic


The TMS-Cobot is the only FDA cleared robotic TMS solution for MagVenture TMS Therapy. MagVenture is proud to be partners with Axilum Robotics in offering a solution to significantly eliminate patient operator contact during routine TMS procedures.

What are the general advantages of The TMS-Cobot?

  1. The TMS-Cobot, with its optical Tracking System, controls the real-time position, orientation and tilt of the TMS coil during the session. There is no need for the operator to adjust coil position during the session.
  2. Automatically compensates for potential head motion during the TMS session and reduces the movement constraint of the patient.
  3. Maintains contact between the coil and head with its integrated contact sensor.

Learning objectives

  • Introduction to Robotic TMS;
  • TMS-Cobot implementation and how it works to reduce patient and operator interaction;
  • Demonstration of the FDA cleared TMS-Cobot.


Michel Berg, MD, CEO of Axilum Robotics

Dr. Berg is a medical doctor and a business school graduate, he built his experience within the pharmaceutical and medical device industry before co-founding Axilum Robotics in 2011 with a team of experts in medical robotics.

Rustin Berlow, MD

Dr. Berlow is a psychiatrist in a California private practice with years of TMS experience. He graduated from Columbia University College of Physicians and Surgeons medical school in 1990. After 23 years of psychopharmacology Dr. Berlow added procedural diagnosis & brain stimulation. Initial visit includes HRV, GSR and EEG. Magnetic stim: rTMS, TBS, accelerated, deep TMS. Electric stim: tDCS, tACS, Trigeminal and tVNS (Transcutaneous Vagus Nerve Stimulation). EEG-TMS - how to predict and personalize treatment).

Register Here
About MagVenture


MagVenture TMS Therapy® was used for the world’s largest RCT with TMS to date (Blumberger et al, 2018, The Lancet: “THREE-D: a randomised non-inferiority trial”), comparing the standard, 37 minute TMS protocol to the newer, 3 minute Theta Burst protocol. The study concluded that the Theta Burst protocol is just as safe and effective for the treatment of major depressive disorder as standard TMS. In 2018, MagVenture received FDA clearance for the 3 minute protocol which we market under the trademarked name Express TMS®. MagVenture is also FDA cleared for the standard 37 minute protocol as well as the 19 minute protocol. MagVenture has a long-standing legacy within the neuroscience community, providing TMS solutions to researchers since 1992. We are confident that new treatment options and discoveries will emerge as our knowledge of the human brain increases and the research matures enough to establish the efficacy and safety of a given application.